Journal of Woundcare Handbook

The professional's guide to wound product selection



Urgo Medical


Soft-absorbent foam dressing containing a protease inhibitor (TLC-NOSF Healing Matrix). The TLC-NOSF Healing Matrix inhibits matrix metalloproteinases and promotes the formation of new blood vessels. NICE 2019 medical technology guidance (MTG42) states that evidence supports the case for adopting UrgoStart dressings to treat diabetic foot ulcers and venous leg ulcers.



Low to moderately exuding leg ulcers, diabetic foot ulcers, pressure ulcers and long-standing acute wounds. 


Do not use on infected or critically colonised wounds, cancerous wounds, fistulas, which may reveal a deep abscess, or if there is a known sensitivity to the dressing.

Sizes Available

6x6cm; 10x10cm; 15x20cm, 12x19cm (heel)


£4.77; £6.60; £11.88; £9.10 (heel)

More on: Foams , Protease modulating dressings